TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.
ResMed Inc. announced a change in beneficial ownership involving Peter C. Farrell, a director and significant shareholder of the company. Farrell acquired 536 shares of ResMed common stock, which were awarded as Restricted Stock Units (RSUs) that will vest in full by November 2026 or at the next annual stockholders’ meeting. This transaction reflects ongoing changes in the company’s ownership structure, potentially impacting shareholder dynamics and corporate governance.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Average Trading Volume: 1,214,271
Technical Sentiment Signal: Buy
Current Market Cap: A$56.69B
Find detailed analytics on RMD stock on TipRanks’ Stock Analysis page.